Gulf Pharmaceutical Industries
Last Updated:
- 0.960 AED
- -0.004
- -0.41%
شركة الخليج للصناعات الدوائية
جلفار
Symbol :
JULPHAR
ISIN :
AEG000201018
52-Week Range :
0.701
-
1.410
Turnover Ratio :
0.33
Market :
Abu Dhabi Securities Exchange
Sector :
Health Care
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Basic Information
-
Activity :Gulf Pharmaceutical Industries (known as: Julphar) is a public company, listed on Abu Dhabi Securities Exchange (ADX) since July 2005. Julphar operates within the Pharmaceuticals, Biotechnology and Life...
-
Industry Group :pharmaceuticals Research and Biotechnology
-
Sub-Industry :
-
ISIN :AEG000201018
-
Contact Person :
-
Established On:30-Mar-1980
-
Stock Listing On :20-Oct-2002
-
No of Employees :3,000 Employees as of 2017
-
Outstanding Shares :1,155,227,811
-
Free Float Shares :
-
Par Value :
-
Paid Capital :
-
Market Cap :
-
Authorized Capital :
Indices Membership
| Action | Date | Index | Provider |
|---|---|---|---|
| Join | 2002 | Abu Dhabi General Index | Abu Dhabi Securities Exchange |
| Join | 2002 | Industrial | Abu Dhabi Securities Exchange |
| Gulf Pharmaceutical Industries |
| P.O. Box: 997, Digdaga, Ras Al Khaimah, UAE |
| T : +971 7 2461461 |
| F : +971 7 2462462 |
| www.julphar.net |
| info@julphar.net |
Management
| Title | Name | As Of |
|---|---|---|
| Chairman: | Saqr Al Qasimi | 2019 |
| CEO: | Essam Ahmed | 2020 |
| Deputy Chairman: | Rabih Khouri | 2021 |
| Board Member: | Abdulaziz Alzaabi | 2019 |
| Medhat Abo AlAsrar | 2019 | |
| Raman Garg | 2020 | |
| Abboud Bejjani | 2020 | |
| Olfa Gam | 2021 | |
| Jean Diab | 2023 | |
| Hamodi Al Limy |
Reports
| Date | Title | File |
|---|---|---|
| 2024 | Julphar Annual Financials Report 2023 | |
| 2023 | Julphar Quarterly Financials Report Q3 2023 | |
| 2023 | Julphar Quarterly Financials Report Q2 2023 | |
| 2023 | Julphar Quarterly Financials Report Q1 2023 | |
| 2023 | Julphar Annual Financials Report 2022 | |
| 2022 | Julphar announces robust Q2 2022 results marking a return to profitability | |
| 2022 | Julphar Quarterly Financials Report Q2 2022 | |
| 2022 | Gulf Pharmaceutical Industries Julphar announces Q1 2022 results; delivers robust top and bottom-line growth | |
| 2022 | Julphar Quarterly Financials Report Q1 2022 | |
| 2022 | Julphar Holds Annual General Meeting for the Year Ending 31 December 2021 | |
| 2022 | Julphar reports strong full year 2021 results |
